Skip to main content
Beta Drugs Limited logo

Beta Drugs Limited — Investor Relations & Filings

Ticker · BETA ISIN · INE351Y01019 LEI · 984500A89888DB9E6T57 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 431 across all filing types
Latest filing 2020-07-06 Board/Management Inform…
Country IN India
Listing National Stock Exchange of India BETA

About Beta Drugs Limited

https://www.betadrugslimited.com

Beta Drugs Limited specializes in the development, manufacture, and marketing of oncology formulations. The company provides a comprehensive portfolio of anti-cancer drugs across various therapeutic segments, including cytotoxic injectables, lyophilized products, tablets, and capsules. Its manufacturing capabilities encompass a wide range of oncology treatments such as chemotherapy agents and supportive care medications. The organization operates advanced production facilities designed to meet international quality standards, focusing on high-potency active pharmaceutical ingredients and finished dosage forms. The company serves diverse markets through its own branded products and contract manufacturing services, aiming to provide affordable and high-quality cancer care solutions. Its core competency lies in its specialized focus on the oncology niche and its integrated approach to pharmaceutical production.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a short letter addressed to the National Stock Exchange of India Limited reporting the outcome of a Board Meeting held on 6th July 2020. It mentions the approval of an investment by the Board of Directors. The document is brief (1339 characters) and serves as an announcement of the board meeting outcome rather than a detailed report or financial statement. It does not contain financial data or detailed management discussion, nor is it a regulatory certification or voting result. The content fits best with Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2020-07-06 English
Updates
Regulatory Filings Classification · 95% confidence The document is a communication addressed to the National Stock Exchange of India regarding the impact of the COVID-19 pandemic on the company's business operations. It references a SEBI circular dated May 20, 2020, and provides detailed information on operational impacts, financial resources, liquidity, debt servicing, and other business aspects related to COVID-19. The document is a regulatory update or compliance disclosure rather than a full financial report or earnings release. It does not contain comprehensive financial statements or detailed financial analysis typical of Annual Reports (10-K), Interim Reports (IR), or Earnings Releases (ER). It also does not announce voting results, management changes, or capital structure changes. Given the nature of the content and the reference to a SEBI circular, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2020-06-23 English
Outcome of Board Meeting
Regulatory Filings Classification · 100% confidence The document text is extremely short (62 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous filings.
2020-06-17 English
Outcome of Board Meeting
Regulatory Filings Classification · 100% confidence The document text is extremely short (62 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document does not fit any specific category and defaults to the fallback category for miscellaneous filings.
2020-06-17 English
Reply to Clarification Sought
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to the National Stock Exchange of India Limited regarding a clarification about an announcement on 'New Product Launches' for the company BETA. It references an email and an announcement but does not contain any financial data, report, or detailed information. The length is only 992 characters, indicating it is a brief communication rather than a full report. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings with substantive content. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement or clarification that does not fit other specific categories.
2020-06-16 English
Reply to Clarification- Financial results
Interim / Quarterly Report Classification · 95% confidence The document contains an Independent Auditor's Report on consolidated half yearly and annual financial results for the period ended 31st March 2020. It references Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly and half yearly financial results. The report includes detailed audit opinions, basis for opinion, auditor responsibilities, and financial data tables for half yearly and annual periods. The presence of audited consolidated financial results and detailed financial figures confirms this is a financial report rather than an announcement or certification. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement. Therefore, the document is best classified as an Interim / Quarterly Report (IR), as it covers half yearly financial results with substantive financial data and audit opinion.
2020-06-16 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.